Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2026-05-20 09:03:22 ET · period of report 2026-05-18 · accession 0001683168-26-004145 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-20 09:03 | 2026-05-18 | CNSP | Charles Faith L. | Dir | P - Purchase | $4.79 | +7,100 | 7,100 | New | +$34.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-18 | P | A | 7,100 | $4.79 | 7,100 | D | — | — |